UMECLIDINIUM

UMECLIDINIUM was reported 43081 times

UMECLIDINIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CONGENITAL METHAEMOGLOBINAEMIA 5 0.5000
1 TESTICULAR INFARCTION 13 0.2167
2 INSPIRATORY CAPACITY ABNORMAL 6 0.2143
3 COAGULATION FACTOR V LEVEL ABNORMAL 18 0.1463
4 ACQUIRED FACTOR V DEFICIENCY 16 0.1455
5 COAGULATION FACTOR DEFICIENCY 17 0.1056
6 APPENDICOLITH 18 0.0465
7 BACTEROIDES INFECTION 12 0.0460
8 NSAID EXACERBATED RESPIRATORY DISEASE 16 0.0423
9 MESENTERITIS 6 0.0397
10 FACTOR V LEIDEN MUTATION 15 0.0378
11 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 28 0.0302
12 BRONCHOSPASM PARADOXICAL 8 0.0266
13 SLEEP DISORDER THERAPY 5 0.0253
14 PRODUCT CONFUSION 19 0.0239
15 INFECTIVE EXACERBATION OF BRONCHIECTASIS 7 0.0228
16 PULMONARY RESECTION 5 0.0202
17 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 10 0.0191
18 VOCAL CORD INFLAMMATION 5 0.0169
19 BRONCHIAL WALL THICKENING 12 0.0167
20 PROGRESSIVE MULTIPLE SCLEROSIS 19 0.0165
21 TOTAL LUNG CAPACITY DECREASED 25 0.0156
22 ANALGESIC THERAPY 5 0.0156
23 DRUG THERAPY 5 0.0147
24 CARDIO-RESPIRATORY DISTRESS 4 0.0140
25 DEVICE USE CONFUSION 7 0.0134
26 PAROTITIS 15 0.0129
27 TOTAL LUNG CAPACITY ABNORMAL 5 0.0129
28 BLOOD FOLATE DECREASED 9 0.0124
29 VIRAL RASH 5 0.0123
30 DUST ALLERGY 12 0.0122
31 TESTICULAR DISORDER 12 0.0119
32 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 547 0.0117
33 PRODUCT COMPLAINT 283 0.0112
34 NASAL CRUSTING 7 0.0108
35 LUNG HYPERINFLATION 9 0.0105
36 INTERCEPTED DRUG PRESCRIBING ERROR 5 0.0101
37 SPUTUM DISCOLOURED 95 0.0100
38 HALO VISION 11 0.0097
39 LUNG CARCINOMA CELL TYPE UNSPECIFIED RECURRENT 6 0.0097
40 TESTICULAR SWELLING 12 0.0095
41 ALLERGY TO ANIMAL 10 0.0094
42 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 7 0.0092
43 MITE ALLERGY 6 0.0092
44 LABELLED DRUG-DISEASE INTERACTION MEDICATION ERROR 5 0.0086
45 SPIROMETRY ABNORMAL 5 0.0084
46 LUNG OPERATION 7 0.0084
47 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 73 0.0082
48 LOWER RESPIRATORY TRACT CONGESTION 14 0.0082
49 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 420 0.0080
50 INCREASED BRONCHIAL SECRETION 20 0.0078
51 MULTIPLE ALLERGIES 61 0.0078
52 OBSTRUCTIVE AIRWAYS DISORDER 86 0.0077
53 PULMONARY FUNCTION TEST ABNORMAL 12 0.0077
54 RESTRICTIVE PULMONARY DISEASE 9 0.0077
55 RESPIRATORY TRACT IRRITATION 8 0.0077
56 BLOOD IMMUNOGLOBULIN E INCREASED 18 0.0074
57 FULL BLOOD COUNT ABNORMAL 78 0.0074
58 PLEURAL THICKENING 5 0.0073
59 OXYGEN THERAPY 12 0.0073
60 BURNING MOUTH SYNDROME 4 0.0071
61 FORCED EXPIRATORY VOLUME DECREASED 19 0.0067
62 PRODUCT PACKAGING CONFUSION 16 0.0066
63 CHONDROCALCINOSIS PYROPHOSPHATE 5 0.0065
64 SPUTUM INCREASED 14 0.0065
65 CHOREA 11 0.0064
66 HIGH DENSITY LIPOPROTEIN DECREASED 21 0.0063
67 INFUSION SITE DISCHARGE 11 0.0063
68 PRODUCT LABEL CONFUSION 36 0.0062
69 DRUG DISPENSING ERROR 94 0.0061
70 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 104 0.0061
71 LUNG OPACITY 16 0.0061
72 MYCOTIC ALLERGY 5 0.0058
73 WHEEZING 341 0.0057
74 VASCULAR PURPURA 8 0.0057
75 NASAL POLYPS 28 0.0057
76 ASTHMA 640 0.0057
77 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 6 0.0056
78 RED CELL DISTRIBUTION WIDTH INCREASED 23 0.0055
79 NOCTURNAL DYSPNOEA 7 0.0055
80 CATHETER SITE SWELLING 5 0.0053
81 CHOKING SENSATION 29 0.0053
82 PNEUMONIA PSEUDOMONAL 8 0.0052
83 BRONCHIECTASIS 35 0.0052
84 BLOOD PHOSPHORUS INCREASED 14 0.0051
85 BREATH SOUNDS ABNORMAL 25 0.0051
86 CHRONIC RESPIRATORY FAILURE 6 0.0050
87 DEVICE USE ERROR 169 0.0049
88 INFUSION SITE DISCOMFORT 5 0.0048
89 BONE DEMINERALISATION 5 0.0047
90 INFUSION SITE IRRITATION 6 0.0047
91 IRON DEFICIENCY 21 0.0047
92 URINE FLOW DECREASED 11 0.0046
93 PRODUCTIVE COUGH 218 0.0046
94 ORAL MUCOSAL ERUPTION 7 0.0046
95 MEGACOLON 7 0.0045
96 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 9 0.0044
97 BONE CONTUSION 4 0.0044
98 RHONCHI 6 0.0043
99 PULMONARY FUNCTION TEST DECREASED 19 0.0043
100 HYPERCAPNIA 13 0.0043
101 ANGLE CLOSURE GLAUCOMA 11 0.0043
102 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 204 0.0042
103 DEVICE DISPENSING ERROR 5 0.0042
104 HYPERPHOSPHATAEMIA 9 0.0042
105 OBSTRUCTIVE SLEEP APNOEA SYNDROME 6 0.0041
106 TESTICULAR PAIN 13 0.0041
107 PULMONARY CONGESTION 54 0.0041
108 BRONCHITIS CHRONIC 10 0.0041
109 AORTIC STENOSIS 14 0.0040
110 INTENTIONAL UNDERDOSE 29 0.0040
111 FRACTURED COCCYX 5 0.0039
112 RESPIRATORY SYMPTOM 11 0.0039
113 FOREIGN BODY IN RESPIRATORY TRACT 5 0.0038
114 PRODUCT DISPENSING ERROR 83 0.0038
115 BODY MASS INDEX INCREASED 5 0.0037
116 INFUSION SITE BRUISING 8 0.0037
117 DYSPNOEA EXERTIONAL 138 0.0037
118 AORTIC DILATATION 4 0.0036
119 LARGE INTESTINAL OBSTRUCTION 8 0.0036
120 OXYGEN SATURATION ABNORMAL 10 0.0035
121 PHYSICAL DECONDITIONING 9 0.0035
122 THROAT CLEARING 13 0.0035
123 DEVICE DEPOSIT ISSUE 7 0.0034
124 KYPHOSIS 6 0.0034
125 EMPHYSEMA 34 0.0034
126 SUBILEUS 7 0.0034
127 BRONCHIAL HYPERREACTIVITY 4 0.0033
128 INFUSION SITE SWELLING 20 0.0032
129 BRONCHIAL SECRETION RETENTION 4 0.0031
130 EOSINOPHIL COUNT INCREASED 26 0.0031
131 REHABILITATION THERAPY 12 0.0031
132 TONGUE DISCOMFORT 13 0.0031
133 CATARACT OPERATION 18 0.0030
134 IMPAIRED QUALITY OF LIFE 43 0.0030
135 OVERWEIGHT 16 0.0030
136 SEASONAL ALLERGY 42 0.0030
137 CARBON DIOXIDE INCREASED 4 0.0029
138 DIASTOLIC DYSFUNCTION 9 0.0029
139 CANDIDA INFECTION 49 0.0029
140 DYSPHONIA 169 0.0029
141 MICTURITION DISORDER 10 0.0029
142 CARDIOVERSION 4 0.0029
143 INFUSION SITE PRURITUS 9 0.0028
144 BRONCHIAL OBSTRUCTION 4 0.0028
145 INTERCEPTED MEDICATION ERROR 13 0.0028
146 AORTIC VALVE STENOSIS 5 0.0028
147 RESPIRATION ABNORMAL 19 0.0028
148 OBSTRUCTION 11 0.0028
149 MEAN CELL VOLUME INCREASED 7 0.0027
150 COLONOSCOPY 6 0.0027
151 INTENTIONAL DEVICE MISUSE 12 0.0027
152 INABILITY TO AFFORD MEDICATION 27 0.0027
153 SECRETION DISCHARGE 34 0.0027
154 RESPIRATORY TRACT INFECTION 70 0.0027
155 CREPITATIONS 8 0.0027
156 CHOKING 52 0.0027
157 SENSITIVITY TO WEATHER CHANGE 14 0.0027
158 COUGH 735 0.0026
159 INFUSION SITE ERYTHEMA 22 0.0026
160 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 16 0.0026
161 ATELECTASIS 25 0.0026
162 RALES 15 0.0026
163 BRONCHIAL DISORDER 4 0.0026
164 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 13 0.0026
165 PRODUCT DOSE OMISSION 167 0.0026
166 ORAL FUNGAL INFECTION 7 0.0026
167 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 181 0.0025
168 DYSPNOEA 1437 0.0025
169 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 6 0.0025
170 OXYGEN CONSUMPTION INCREASED 6 0.0025
171 HYPERVOLAEMIA 12 0.0024
172 ARTHROPOD STING 4 0.0024
173 PULMONARY PAIN 7 0.0024
174 RESPIRATORY TRACT CONGESTION 38 0.0024
175 POTENTIATING DRUG INTERACTION 8 0.0024
176 BLOOD COUNT ABNORMAL 36 0.0024
177 MIDDLE INSOMNIA 44 0.0024
178 LACTOSE INTOLERANCE 6 0.0023
179 LOWER RESPIRATORY TRACT INFECTION 106 0.0023
180 TOOTH INJURY 10 0.0023
181 APHONIA 32 0.0023
182 URINARY RETENTION 76 0.0023
183 RHINITIS ALLERGIC 10 0.0022
184 MYCOBACTERIUM AVIUM COMPLEX INFECTION 6 0.0022
185 MYASTHENIA GRAVIS 18 0.0022
186 HOSPICE CARE 22 0.0022
187 PULMONARY MASS 33 0.0022
188 SKIN LACERATION 24 0.0022
189 ASTHMATIC CRISIS 8 0.0022
190 ACUTE RESPIRATORY FAILURE 42 0.0022
191 BRONCHITIS 161 0.0022
192 INFUSION SITE PAIN 28 0.0022
193 IRON DEFICIENCY ANAEMIA 20 0.0022
194 ANTIPSYCHOTIC DRUG LEVEL INCREASED 6 0.0021
195 OXYGEN SATURATION DECREASED 119 0.0021
196 INGROWING NAIL 5 0.0021
197 LUNG DISORDER 103 0.0021
198 PHARYNGEAL DISORDER 6 0.0021
199 BLOOD URIC ACID INCREASED 12 0.0021
200 PAINFUL RESPIRATION 5 0.0021
201 DRY THROAT 21 0.0021
202 ORAL CANDIDIASIS 27 0.0020
203 APPENDICITIS 19 0.0020
204 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 11 0.0020
205 DEVICE INFUSION ISSUE 5 0.0020
206 EXTRA DOSE ADMINISTERED 81 0.0020
207 BLOOD TEST ABNORMAL 28 0.0020
208 REBOUND ACID HYPERSECRETION 6 0.0020
209 PSEUDOMONAS INFECTION 17 0.0020
210 TROPONIN INCREASED 15 0.0020
211 RETCHING 42 0.0020
212 DYSAESTHESIA 6 0.0020
213 INCREASED UPPER AIRWAY SECRETION 10 0.0019
214 UPPER-AIRWAY COUGH SYNDROME 16 0.0019
215 TENDERNESS 20 0.0019
216 THROAT IRRITATION 86 0.0019
217 MOUTH SWELLING 11 0.0019
218 BRONCHOSPASM 27 0.0019
219 DECREASED ACTIVITY 20 0.0019
220 TONGUE DISCOLOURATION 8 0.0018
221 NEAR DEATH EXPERIENCE 6 0.0018
222 CONGENITAL ANOMALY 14 0.0018
223 FAECES HARD 7 0.0018
224 TONGUE DISORDER 13 0.0018
225 PNEUMONIA 578 0.0018
226 SLEEP APNOEA SYNDROME 34 0.0018
227 OESOPHAGEAL PAIN 7 0.0018
228 OROPHARYNGEAL DISCOMFORT 16 0.0018
229 HYPOPHOSPHATAEMIA 13 0.0018
230 ENDOCARDITIS 9 0.0018
231 DUODENAL ULCER HAEMORRHAGE 5 0.0017
232 VASCULAR GRAFT 5 0.0017
233 GOUT 31 0.0017
234 NEPHROGENIC ANAEMIA 8 0.0017
235 CHEST DISCOMFORT 176 0.0017
236 PNEUMOTHORAX 27 0.0017
237 SPINAL STENOSIS 7 0.0017
238 SARCOIDOSIS 8 0.0017
239 CARDIAC PACEMAKER INSERTION 10 0.0017
240 HYPERLIPIDAEMIA 20 0.0017
241 LUNG NEOPLASM MALIGNANT 68 0.0017
242 ATRIOVENTRICULAR BLOCK SECOND DEGREE 5 0.0016
243 CHEST X-RAY ABNORMAL 5 0.0016
244 COLITIS ISCHAEMIC 11 0.0016
245 BRAIN NATRIURETIC PEPTIDE INCREASED 5 0.0016
246 VENTRICULAR FIBRILLATION 18 0.0016
247 INTENTIONAL DOSE OMISSION 46 0.0016
248 CARDIOGENIC SHOCK 23 0.0016
249 BLOOD CALCIUM INCREASED 14 0.0016
250 RHINORRHOEA 103 0.0016
251 END STAGE RENAL DISEASE 29 0.0016
252 PARANASAL SINUS DISCOMFORT 6 0.0016
253 CLAVICLE FRACTURE 6 0.0016
254 PRODUCT TASTE ABNORMAL 21 0.0015
255 NASAL CONGESTION 91 0.0015
256 UPPER RESPIRATORY TRACT INFECTION 71 0.0015
257 PROSTATOMEGALY 6 0.0015
258 RESPIRATORY ACIDOSIS 6 0.0015
259 INFUSION SITE HAEMORRHAGE 5 0.0015
260 EYE OPERATION 7 0.0015
261 SINUS DISORDER 30 0.0015
262 RESPIRATORY DISORDER 45 0.0015
263 ATRIOVENTRICULAR BLOCK COMPLETE 10 0.0015
264 VIRAL UPPER RESPIRATORY TRACT INFECTION 7 0.0015
265 LIMB OPERATION 7 0.0015
266 FACIAL PAIN 13 0.0015
267 GLAUCOMA 28 0.0015
268 HYPOPNOEA 5 0.0014
269 FOOT FRACTURE 27 0.0014
270 THROAT CANCER 6 0.0014
271 DRUG DOSE OMISSION 234 0.0014
272 INCORRECT DRUG ADMINISTRATION RATE 6 0.0014
273 ABDOMINAL TENDERNESS 7 0.0014
274 SINUS CONGESTION 19 0.0014
275 INTERVERTEBRAL DISC DISORDER 6 0.0014
276 PULMONARY HYPERTENSION 29 0.0014
277 PARAESTHESIA ORAL 20 0.0014
278 ORAL PAIN 31 0.0014
279 ULCER 22 0.0014
280 RESPIRATORY SYNCYTIAL VIRUS INFECTION 12 0.0014
281 RIB FRACTURE 28 0.0014
282 BLINDNESS TRANSIENT 10 0.0014
283 CATHETERISATION CARDIAC 6 0.0014
284 BLOOD IRON DECREASED 16 0.0013
285 PRODUCT PRESCRIBING ERROR 32 0.0013
286 MACULAR DEGENERATION 16 0.0013
287 URINARY TRACT DISORDER 6 0.0013
288 PHARYNGEAL SWELLING 13 0.0013
289 EXPIRED PRODUCT ADMINISTERED 44 0.0013
290 ABNORMAL LOSS OF WEIGHT 9 0.0013
291 DISEASE COMPLICATION 6 0.0013
292 INSURANCE ISSUE 20 0.0013
293 PNEUMONIA BACTERIAL 12 0.0013
294 ORAL DISCOMFORT 18 0.0013
295 HIP SURGERY 7 0.0013
296 PRESCRIBED OVERDOSE 25 0.0013
297 HAEMOPTYSIS 36 0.0013
298 LIMB INJURY 35 0.0013
299 OSTEOPOROSIS 53 0.0013
300 INFUSION SITE EXTRAVASATION 8 0.0013
301 RHINOVIRUS INFECTION 5 0.0013
302 FAECALOMA 7 0.0013
303 BLOOD MAGNESIUM DECREASED 11 0.0013
304 COVID-19 PNEUMONIA 15 0.0013
305 SKIN ABRASION 6 0.0013
306 CYSTIC FIBROSIS 7 0.0013
307 NASAL DISCOMFORT 10 0.0013
308 OESOPHAGEAL CANDIDIASIS 5 0.0013
309 HYPOXIA 44 0.0012
310 BLOOD TRIGLYCERIDES INCREASED 22 0.0012
311 OROPHARYNGEAL PAIN 115 0.0012
312 INFLUENZA 138 0.0012
313 UNDERDOSE 90 0.0012
314 BLOOD PRESSURE SYSTOLIC INCREASED 24 0.0012
315 EXERCISE TOLERANCE DECREASED 7 0.0012
316 SINUSITIS 124 0.0012
317 CORONAVIRUS INFECTION 8 0.0012
318 PRODUCT DOSE OMISSION ISSUE 354 0.0012
319 STRESS CARDIOMYOPATHY 7 0.0012
320 CARDIAC FAILURE ACUTE 8 0.0012
321 LOWER LIMB FRACTURE 23 0.0012
322 ASPIRATION 13 0.0012
323 DRY MOUTH 96 0.0012
324 SYMPTOM RECURRENCE 7 0.0012
325 LEFT VENTRICULAR HYPERTROPHY 5 0.0012
326 CARDIAC OPERATION 10 0.0012
327 BENIGN PROSTATIC HYPERPLASIA 6 0.0012
328 HOSPITALISATION 178 0.0012
329 ASCITES 34 0.0012
330 FAILURE TO THRIVE 6 0.0012
331 ILL-DEFINED DISORDER 70 0.0012
332 CHAPPED LIPS 5 0.0012
333 INGUINAL HERNIA 7 0.0011
334 DIVERTICULUM INTESTINAL 5 0.0011
335 DERMATITIS CONTACT 13 0.0011
336 MENISCUS INJURY 7 0.0011
337 TRICUSPID VALVE INCOMPETENCE 9 0.0011
338 ACUTE RESPIRATORY DISTRESS SYNDROME 20 0.0011
339 GINGIVAL PAIN 9 0.0011
340 MULTIPLE ORGAN DYSFUNCTION SYNDROME 32 0.0011
341 HAND FRACTURE 8 0.0011
342 PHARYNGITIS 14 0.0011
343 BACK INJURY 12 0.0011
344 ANKLE FRACTURE 17 0.0011
345 SPINAL FRACTURE 22 0.0011
346 HERNIA 21 0.0011
347 BLOOD PRESSURE DIASTOLIC DECREASED 8 0.0011
348 INTERVERTEBRAL DISC DEGENERATION 10 0.0011
349 CATARACT 64 0.0011
350 BACTERIAL INFECTION 20 0.0011
351 SNEEZING 24 0.0011
352 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 36 0.0011
353 CHRONIC SINUSITIS 4 0.0011
354 PERIORBITAL SWELLING 6 0.0011
355 DYSURIA 39 0.0011
356 WEIGHT FLUCTUATION 11 0.0011
357 GASTRIC HAEMORRHAGE 12 0.0010
358 FOOD ALLERGY 8 0.0010
359 POSTOPERATIVE WOUND INFECTION 7 0.0010
360 ATRIOVENTRICULAR BLOCK 8 0.0010
361 NEURALGIA 25 0.0010
362 ANHEDONIA 27 0.0010
363 PELVIC FRACTURE 8 0.0010
364 GROIN PAIN 9 0.0010
365 PRODUCT ADMINISTRATION INTERRUPTED 8 0.0010
366 GASTROOESOPHAGEAL REFLUX DISEASE 82 0.0010
367 PRODUCT USE IN UNAPPROVED INDICATION 252 0.0010
368 BODY TEMPERATURE DECREASED 10 0.0010
369 LIGAMENT SPRAIN 10 0.0010
370 FOOT OPERATION 5 0.0010
371 SINUS HEADACHE 6 0.0010
372 PULMONARY THROMBOSIS 11 0.0010
373 RENAL CYST 8 0.0010
374 ANEURYSM 5 0.0010
375 THROAT TIGHTNESS 27 0.0010
376 STENT PLACEMENT 8 0.0010
377 ILLNESS 102 0.0010
378 NASOPHARYNGITIS 182 0.0010
379 CORONARY ARTERIAL STENT INSERTION 5 0.0010
380 POST PROCEDURAL INFECTION 8 0.0010
381 INTESTINAL OBSTRUCTION 37 0.0010
382 RESPIRATORY DISTRESS 27 0.0010
383 PHARYNGEAL OEDEMA 15 0.0010
384 EYE PAIN 55 0.0010
385 INTENTIONAL PRODUCT MISUSE 85 0.0010
386 PULMONARY OEDEMA 43 0.0010
387 ATTENTION DEFICIT HYPERACTIVITY DISORDER 4 0.0009
388 SENSATION OF FOREIGN BODY 8 0.0009
389 PHOTOPSIA 6 0.0009
390 SKIN PLAQUE 8 0.0009
391 CORONARY ARTERY OCCLUSION 13 0.0009
392 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 170 0.0009
393 BUNDLE BRANCH BLOCK LEFT 4 0.0009
394 DYSGEUSIA 70 0.0009
395 SCIATICA 15 0.0009
396 TOOTHACHE 17 0.0009
397 HEART RATE INCREASED 93 0.0009
398 DRUG EFFECT INCOMPLETE 34 0.0009
399 BODY HEIGHT DECREASED 10 0.0009
400 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 16 0.0009
401 HEREDITARY ANGIOEDEMA 10 0.0009
402 ANURIA 8 0.0009
403 HEART RATE IRREGULAR 21 0.0009
404 DIZZINESS POSTURAL 9 0.0009
405 PRODUCT QUALITY ISSUE 126 0.0009
406 PRODUCT RESIDUE PRESENT 5 0.0009
407 WRIST FRACTURE 11 0.0009
408 INTERCEPTED PRODUCT ADMINISTRATION ERROR 7 0.0009
409 PERICARDIAL EFFUSION 21 0.0009
410 PRODUCT COMMUNICATION ISSUE 8 0.0009
411 DIVERTICULITIS 25 0.0009
412 STREPTOCOCCAL INFECTION 5 0.0009
413 SWOLLEN TONGUE 28 0.0009
414 ATRIAL FIBRILLATION 87 0.0009
415 HAEMOLYTIC ANAEMIA 8 0.0009
416 OCULAR DISCOMFORT 10 0.0009
417 ANAL INCONTINENCE 8 0.0009
418 TASTE DISORDER 18 0.0009
419 PULMONARY FIBROSIS 17 0.0009
420 PNEUMONITIS 24 0.0009
421 OBESITY 14 0.0009
422 ATRIAL FLUTTER 7 0.0009
423 ABDOMINAL HERNIA 4 0.0009
424 CONDITION AGGRAVATED 266 0.0009
425 NEUROLOGICAL SYMPTOM 5 0.0009
426 EAR PAIN 17 0.0009
427 VIRAL INFECTION 29 0.0009
428 POOR VENOUS ACCESS 9 0.0009
429 NERVE COMPRESSION 8 0.0009
430 BLOOD PRESSURE DIASTOLIC INCREASED 4 0.0009
431 PRODUCT DISTRIBUTION ISSUE 8 0.0009
432 HEPATIC ENCEPHALOPATHY 8 0.0009
433 RIGHT VENTRICULAR FAILURE 6 0.0009
434 FLANK PAIN 8 0.0009
435 UPPER LIMB FRACTURE 17 0.0009
436 PHOTOPHOBIA 16 0.0008
437 GLUCOSE TOLERANCE IMPAIRED 5 0.0008
438 PERIPHERAL SWELLING 129 0.0008
439 LUNG INFECTION 13 0.0008
440 SARS-COV-2 TEST POSITIVE 11 0.0008
441 PANIC REACTION 6 0.0008
442 PULMONARY ARTERIAL HYPERTENSION 12 0.0008
443 LACRIMATION INCREASED 25 0.0008
444 EAR INFECTION 22 0.0008
445 QUALITY OF LIFE DECREASED 11 0.0008
446 VITAMIN D DECREASED 7 0.0008
447 LETHARGY 47 0.0008
448 TOOTH FRACTURE 9 0.0008
449 HYPOACUSIS 35 0.0008
450 DRUG EFFECT LESS THAN EXPECTED 12 0.0008
451 BLADDER DISORDER 8 0.0008
452 DEVICE DELIVERY SYSTEM ISSUE 22 0.0008
453 PALPITATIONS 94 0.0008
454 NASAL DRYNESS 5 0.0008
455 CARDIAC FAILURE CONGESTIVE 64 0.0008
456 COVID-19 139 0.0008
457 FEELING COLD 22 0.0008
458 RESPIRATORY RATE INCREASED 7 0.0008
459 FEELING JITTERY 15 0.0008
460 TOOTH ABSCESS 8 0.0008
461 DISSOCIATION 6 0.0008
462 CLOSTRIDIUM DIFFICILE INFECTION 17 0.0008
463 GAIT INABILITY 26 0.0008
464 MUSCULOSKELETAL CHEST PAIN 12 0.0008
465 VASCULITIS 9 0.0008
466 DYSPEPSIA 76 0.0008
467 APNOEA 6 0.0008
468 ANGINA UNSTABLE 5 0.0008
469 KIDNEY INFECTION 15 0.0008
470 TRANSFUSION 8 0.0008
471 FALL 254 0.0008
472 BEDRIDDEN 10 0.0008
473 PNEUMONIA ASPIRATION 19 0.0008
474 CHEST PAIN 140 0.0008
475 FLUID OVERLOAD 11 0.0008
476 CHRONIC KIDNEY DISEASE 57 0.0007
477 SKIN MASS 5 0.0007
478 TERMINAL STATE 5 0.0007
479 HIP FRACTURE 24 0.0007
480 MALAISE 327 0.0007
481 LIVER FUNCTION TEST INCREASED 16 0.0007
482 POOR QUALITY SLEEP 16 0.0007
483 BLOOD SODIUM DECREASED 14 0.0007
484 FRUSTRATION TOLERANCE DECREASED 6 0.0007
485 ADRENAL INSUFFICIENCY 9 0.0007
486 MUSCLE DISORDER 6 0.0007
487 ASPHYXIA 6 0.0007
488 GLOMERULAR FILTRATION RATE DECREASED 9 0.0007
489 SUPRAVENTRICULAR TACHYCARDIA 7 0.0007
490 HICCUPS 6 0.0007
491 SPINAL OPERATION 9 0.0007
492 ECZEMA 38 0.0007
493 PULMONARY EMBOLISM 69 0.0007
494 CYST 9 0.0007
495 DEVICE FAILURE 11 0.0007
496 LIP SWELLING 24 0.0007
497 GASTROENTERITIS VIRAL 13 0.0007
498 POLLAKIURIA 30 0.0007
499 CARDIAC DISORDER 67 0.0007
500 DEMENTIA 20 0.0007
501 GLOSSODYNIA 16 0.0007
502 CELLULITIS 36 0.0007
503 EYE PRURITUS 24 0.0007
504 UPPER GASTROINTESTINAL HAEMORRHAGE 12 0.0007
505 URINARY INCONTINENCE 21 0.0007
506 COLECTOMY 4 0.0007
507 PRODUCT DOSE OMISSION IN ERROR 20 0.0007
508 LOCALISED INFECTION 17 0.0007
509 JOINT INJURY 15 0.0007
510 ADVERSE DRUG REACTION 63 0.0007
511 SCAB 8 0.0007
512 DRY EYE 35 0.0007
513 ANGINA PECTORIS 20 0.0007
514 NECK PAIN 39 0.0007
515 URINARY TRACT INFECTION 119 0.0007
516 CARDIAC MURMUR 6 0.0007
517 HYSTERECTOMY 6 0.0007
518 PLEURAL EFFUSION 42 0.0007
519 FAECES SOFT 5 0.0007
520 RASH PUSTULAR 5 0.0007
521 CONTUSION 66 0.0007
522 HYPERTENSION 145 0.0007
523 SPINAL OSTEOARTHRITIS 6 0.0007
524 ORAL DISORDER 5 0.0007
525 EPISTAXIS 51 0.0007
526 DRUG PRESCRIBING ERROR 13 0.0007
527 ARTHROPOD BITE 5 0.0007
528 EYE DISCHARGE 7 0.0007
529 ACCIDENT 8 0.0007
530 SCRATCH 7 0.0007
531 VISION BLURRED 91 0.0007
532 PAROSMIA 5 0.0007
533 JOINT DISLOCATION 7 0.0007
534 THROMBOSIS 53 0.0007
535 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 133 0.0007
536 IRRITABLE BOWEL SYNDROME 14 0.0007
537 SLEEP DISORDER 46 0.0007
538 CONJUNCTIVITIS 12 0.0006
539 PHARYNGITIS STREPTOCOCCAL 7 0.0006
540 HERPES ZOSTER 37 0.0006
541 DIABETES MELLITUS 49 0.0006
542 SCAR 11 0.0006
543 BACK PAIN 149 0.0006
544 MUSCULOSKELETAL DISCOMFORT 11 0.0006
545 GASTROINTESTINAL INFLAMMATION 5 0.0006
546 ARTERIOSCLEROSIS 6 0.0006
547 ELECTROCARDIOGRAM ABNORMAL 5 0.0006
548 STAPHYLOCOCCAL INFECTION 21 0.0006
549 ARTERIAL OCCLUSIVE DISEASE 5 0.0006
550 LEUKAEMIA 6 0.0006
551 ABDOMINAL DISTENSION 66 0.0006
552 HYPOKALAEMIA 29 0.0006
553 PRODUCT STORAGE ERROR 55 0.0006
554 CONSTIPATION 137 0.0006
555 EOSINOPHILIA 11 0.0006
556 SEPSIS 70 0.0006
557 HEART RATE DECREASED 22 0.0006
558 BLOOD PRESSURE FLUCTUATION 15 0.0006
559 MYOCARDIAL INFARCTION 109 0.0006
560 BLOOD DISORDER 5 0.0006
561 HYPONATRAEMIA 35 0.0006
562 RHINITIS 5 0.0006
563 HYPOKINESIA 9 0.0006
564 OEDEMA PERIPHERAL 75 0.0006
565 BACK DISORDER 10 0.0006
566 MICTURITION URGENCY 7 0.0006
567 NERVOUSNESS 32 0.0006
568 BRADYPHRENIA 4 0.0006
569 VITREOUS FLOATERS 6 0.0006
570 DEPRESSED MOOD 32 0.0006
571 SPINAL COMPRESSION FRACTURE 5 0.0006
572 COLON CANCER 9 0.0006
573 SOPOR 8 0.0006
574 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0006
575 ADVERSE REACTION 8 0.0006
576 ACUTE KIDNEY INJURY 92 0.0006
577 PAIN IN JAW 17 0.0006
578 HEPATIC FAILURE 18 0.0006
579 BREAST MASS 4 0.0006
580 FACE OEDEMA 10 0.0006
581 DRUG INEFFECTIVE 781 0.0006
582 FEEDING DISORDER 12 0.0006
583 DRUG INTOLERANCE 57 0.0006
584 BLOOD PRESSURE INCREASED 90 0.0006
585 FACIAL PARALYSIS 5 0.0006
586 INITIAL INSOMNIA 6 0.0006
587 EAR DISCOMFORT 6 0.0006
588 THYROID DISORDER 9 0.0006
589 SWELLING FACE 38 0.0006
590 PERIPHERAL COLDNESS 8 0.0006
591 LIMB DISCOMFORT 18 0.0006
592 INFECTION 84 0.0006
593 GENERAL PHYSICAL HEALTH DETERIORATION 67 0.0006
594 PYELONEPHRITIS 5 0.0006
595 NOCTURIA 7 0.0006
596 PRESYNCOPE 14 0.0006
597 HYPOMAGNESAEMIA 8 0.0006
598 CARDIAC FAILURE 46 0.0006
599 THERAPEUTIC RESPONSE SHORTENED 19 0.0006
600 URINE OUTPUT DECREASED 5 0.0006
601 BLOOD PRESSURE DECREASED 38 0.0006
602 PRODUCT AVAILABILITY ISSUE 13 0.0006
603 FLUID RETENTION 29 0.0006
604 INCONTINENCE 6 0.0006
605 TENDON RUPTURE 7 0.0006
606 SWELLING 53 0.0006
607 SHOCK 13 0.0006
608 VISUAL IMPAIRMENT 70 0.0006
609 ARTHRITIS 44 0.0006
610 RENAL FAILURE 74 0.0006
611 ASTHENIA 209 0.0006
612 NEOPLASM MALIGNANT 37 0.0006
613 PRODUCT USE ISSUE 104 0.0006
614 DIZZINESS 276 0.0006
615 BLOOD PRESSURE ABNORMAL 11 0.0006
616 OPTIC NEURITIS 5 0.0005
617 PANIC ATTACK 20 0.0005
618 INTRAOCULAR PRESSURE INCREASED 7 0.0005
619 SURGERY 32 0.0005
620 MELAENA 12 0.0005
621 HYPERSENSITIVITY 101 0.0005
622 ANAPHYLACTIC REACTION 30 0.0005
623 DECREASED APPETITE 126 0.0005
624 HYPERKALAEMIA 19 0.0005
625 FOOT DEFORMITY 6 0.0005
626 HIATUS HERNIA 7 0.0005
627 NERVE INJURY 6 0.0005
628 WOUND 15 0.0005
629 NODULE 7 0.0005
630 PANCREATITIS ACUTE 12 0.0005
631 CYSTITIS 17 0.0005
632 TRANSIENT ISCHAEMIC ATTACK 18 0.0005
633 HEADACHE 334 0.0005
634 HEPATIC CIRRHOSIS 10 0.0005
635 EYE INFECTION 6 0.0005
636 TOOTH INFECTION 7 0.0005
637 MYALGIA 90 0.0005
638 GASTRIC ULCER 10 0.0005
639 AORTIC ANEURYSM 4 0.0005
640 CHOLECYSTECTOMY 6 0.0005
641 TREMOR 87 0.0005
642 HYPERSOMNIA 15 0.0005
643 RASH ERYTHEMATOUS 25 0.0005
644 KNEE ARTHROPLASTY 11 0.0005
645 RESPIRATORY FAILURE 38 0.0005
646 BLOOD CREATININE INCREASED 34 0.0005
647 BALANCE DISORDER 45 0.0005
648 SEROTONIN SYNDROME 10 0.0005
649 CONFUSIONAL STATE 84 0.0005
650 CHOLELITHIASIS 17 0.0005
651 APHTHOUS ULCER 4 0.0005
652 DEVICE USE ISSUE 9 0.0005
653 VITAMIN D DEFICIENCY 5 0.0005
654 SPINAL PAIN 6 0.0005
655 SKIN CANCER 11 0.0005
656 DECREASED IMMUNE RESPONSIVENESS 5 0.0005
657 VERTIGO 31 0.0005
658 KNEE OPERATION 5 0.0005
659 ANXIETY 144 0.0005
660 HEAD INJURY 16 0.0005
661 PRODUCT PRESCRIBING ISSUE 11 0.0005
662 HALLUCINATION 38 0.0005
663 FATIGUE 392 0.0005
664 MUSCLE SPASMS 92 0.0005
665 MASS 7 0.0005
666 SALIVARY HYPERSECRETION 5 0.0005
667 PAIN IN EXTREMITY 147 0.0005
668 BLOOD POTASSIUM DECREASED 15 0.0005
669 APHASIA 15 0.0005
670 SPEECH DISORDER 26 0.0005
671 STOMATITIS 30 0.0005
672 BURSITIS 6 0.0005
673 GASTRITIS 13 0.0005
674 MEMORY IMPAIRMENT 67 0.0005
675 WEIGHT DECREASED 136 0.0005
676 HYPERCALCAEMIA 6 0.0005
677 TEMPERATURE INTOLERANCE 5 0.0005
678 FEMUR FRACTURE 15 0.0005
679 WEIGHT INCREASED 108 0.0005
680 COMPLICATION ASSOCIATED WITH DEVICE 7 0.0005
681 ABDOMINAL PAIN 112 0.0005
682 AGEUSIA 12 0.0005
683 GAIT DISTURBANCE 92 0.0005
684 TUBULOINTERSTITIAL NEPHRITIS 9 0.0005
685 FEELING ABNORMAL 115 0.0005
686 DERMATITIS ALLERGIC 6 0.0005
687 TREATMENT NONCOMPLIANCE 26 0.0005
688 ABDOMINAL PAIN LOWER 12 0.0005
689 BLOOD URINE PRESENT 9 0.0005
690 JOINT SWELLING 57 0.0005
691 BLOOD CHOLESTEROL INCREASED 22 0.0005
692 HEPATIC CYTOLYSIS 6 0.0005
693 SYNCOPE 47 0.0005
694 HAEMORRHAGE INTRACRANIAL 7 0.0005
695 INTENTIONAL PRODUCT USE ISSUE 41 0.0005
696 URTICARIA 78 0.0005
697 INSOMNIA 124 0.0005
698 ANAPHYLACTIC SHOCK 12 0.0005
699 HYPOTENSION 93 0.0005
700 THERAPY INTERRUPTED 33 0.0005
701 OSTEOPENIA 7 0.0005
702 FAECES DISCOLOURED 10 0.0005
703 ORAL HERPES 9 0.0005
704 CHILLS 54 0.0005
705 SEPTIC SHOCK 20 0.0005
706 ORTHOSTATIC HYPOTENSION 8 0.0005
707 ARTHRALGIA 191 0.0005
708 ABDOMINAL DISCOMFORT 77 0.0005
709 FLATULENCE 26 0.0005
710 GASTROINTESTINAL PAIN 5 0.0005
711 DENTAL CARIES 5 0.0005
712 HEAD DISCOMFORT 8 0.0005
713 MEDICATION ERROR 25 0.0004
714 MUSCULAR WEAKNESS 51 0.0004
715 OSTEOARTHRITIS 19 0.0004
716 CARDIAC ARREST 37 0.0004
717 MALNUTRITION 5 0.0004
718 GASTROINTESTINAL DISORDER 40 0.0004
719 THERAPEUTIC RESPONSE UNEXPECTED 20 0.0004
720 DYSSTASIA 13 0.0004
721 PRODUCT USE COMPLAINT 7 0.0004
722 MITRAL VALVE INCOMPETENCE 5 0.0004
723 TACHYPNOEA 6 0.0004
724 RESTLESS LEGS SYNDROME 8 0.0004
725 PAIN 270 0.0004
726 INTERNAL HAEMORRHAGE 5 0.0004
727 ACCIDENTAL OVERDOSE 16 0.0004
728 NEOPLASM 5 0.0004
729 DEHYDRATION 58 0.0004
730 BLOOD THYROID STIMULATING HORMONE INCREASED 4 0.0004
731 BRADYCARDIA 23 0.0004
732 MUSCLE TIGHTNESS 7 0.0004
733 MOBILITY DECREASED 31 0.0004
734 HYPOPHAGIA 11 0.0004
735 EYE SWELLING 16 0.0004
736 DIARRHOEA 277 0.0004
737 THERAPEUTIC RESPONSE DECREASED 26 0.0004
738 SOMNOLENCE 86 0.0004
739 DRUG EFFECT DECREASED 23 0.0004
740 DISCOMFORT 26 0.0004
741 EYE DISORDER 14 0.0004
742 SKIN ULCER 11 0.0004
743 BLINDNESS UNILATERAL 6 0.0004
744 DYSARTHRIA 16 0.0004
745 RASH PRURITIC 23 0.0004
746 PRURITUS 163 0.0004
747 OEDEMA 23 0.0004
748 DIPLOPIA 11 0.0004
749 HEPATOCELLULAR INJURY 6 0.0004
750 HYPOCALCAEMIA 8 0.0004
751 ABDOMINAL PAIN UPPER 87 0.0004
752 ARRHYTHMIA 20 0.0004
753 OCULAR HYPERAEMIA 20 0.0004
754 DEAFNESS 11 0.0004
755 SKIN DISORDER 14 0.0004
756 ANAEMIA 80 0.0004
757 MIGRAINE 40 0.0004
758 CHOLESTASIS 8 0.0004
759 ANOSMIA 6 0.0004
760 NEPHROLITHIASIS 19 0.0004
761 CEREBROVASCULAR ACCIDENT 70 0.0004
762 BLISTER 23 0.0004
763 ACUTE MYOCARDIAL INFARCTION 12 0.0004
764 CARDIOMYOPATHY 6 0.0004
765 TACHYCARDIA 36 0.0004
766 DISABILITY 8 0.0004
767 PRESCRIBED UNDERDOSE 8 0.0004
768 MUSCULOSKELETAL PAIN 21 0.0004
769 DYSPHAGIA 38 0.0004
770 DEATH 344 0.0004
771 ECONOMIC PROBLEM 6 0.0004
772 VOMITING 186 0.0004
773 THERAPY CESSATION 20 0.0004
774 TENDONITIS 6 0.0004
775 HAEMATOMA 10 0.0004
776 DEEP VEIN THROMBOSIS 25 0.0004
777 BASAL CELL CARCINOMA 6 0.0004
778 BONE DENSITY DECREASED 12 0.0004
779 DERMATITIS 8 0.0004
780 CYANOSIS 6 0.0004
781 NAUSEA 301 0.0004
782 THERAPEUTIC PRODUCT EFFECT DECREASED 17 0.0004
783 GASTRIC DISORDER 13 0.0004
784 OFF LABEL USE 329 0.0004
785 PYREXIA 130 0.0004
786 BREAST PAIN 4 0.0004
787 DEPRESSION 85 0.0004
788 MENTAL IMPAIRMENT 9 0.0004
789 BLOOD POTASSIUM INCREASED 6 0.0004
790 COLITIS 14 0.0004
791 AMNESIA 24 0.0004
792 BLINDNESS 15 0.0004
793 IMPAIRED HEALING 12 0.0004
794 MULTIPLE FRACTURES 6 0.0004
795 WHITE BLOOD CELL COUNT INCREASED 14 0.0004
796 ERYTHEMA 75 0.0004
797 POST PROCEDURAL COMPLICATION 7 0.0004
798 HAEMATOCHEZIA 20 0.0004
799 FUNGAL INFECTION 12 0.0004
800 GASTROINTESTINAL HAEMORRHAGE 30 0.0004
801 HAEMORRHOIDS 7 0.0004
802 INJECTION SITE PRURITUS 24 0.0004
803 RASH 156 0.0004
804 OVERDOSE 77 0.0004
805 SKIN REACTION 5 0.0004
806 SKIN DISCOLOURATION 16 0.0003
807 PARANOIA 6 0.0003
808 PRODUCT ADMINISTRATION ERROR 7 0.0003
809 HYPOTHYROIDISM 11 0.0003
810 RENAL DISORDER 16 0.0003
811 COLD SWEAT 6 0.0003
812 LYMPHADENOPATHY 12 0.0003
813 SKIN HAEMORRHAGE 5 0.0003
814 THIRST 6 0.0003
815 HAEMORRHAGE 35 0.0003
816 INCORRECT DOSE ADMINISTERED 76 0.0003
817 MOUTH ULCERATION 7 0.0003
818 LEUKOCYTOSIS 6 0.0003
819 VISUAL ACUITY REDUCED 11 0.0003
820 MUSCULOSKELETAL STIFFNESS 29 0.0003
821 EMOTIONAL DISTRESS 40 0.0003
822 EYE IRRITATION 19 0.0003
823 BONE DISORDER 6 0.0003
824 RESTLESSNESS 12 0.0003
825 RESPIRATORY ARREST 9 0.0003
826 TINNITUS 15 0.0003
827 HIP ARTHROPLASTY 5 0.0003
828 RECTAL HAEMORRHAGE 14 0.0003
829 PROCEDURAL PAIN 9 0.0003
830 HYPOAESTHESIA 48 0.0003
831 INTERVERTEBRAL DISC PROTRUSION 7 0.0003
832 BRAIN FOG 5 0.0003
833 HAEMATEMESIS 8 0.0003
834 TRANSAMINASES INCREASED 7 0.0003
835 HALLUCINATION, AUDITORY 5 0.0003
836 RASH MACULAR 11 0.0003
837 AGITATION 23 0.0003
838 METABOLIC ACIDOSIS 10 0.0003
839 RASH PAPULAR 7 0.0003
840 ERECTILE DYSFUNCTION 8 0.0003
841 ROAD TRAFFIC ACCIDENT 13 0.0003
842 ERUCTATION 6 0.0003
843 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 17 0.0003
844 RENAL IMPAIRMENT 26 0.0003
845 BONE PAIN 18 0.0003
846 DRY SKIN 41 0.0003
847 HOT FLUSH 23 0.0003
848 OSTEONECROSIS 10 0.0003
849 LOSS OF CONSCIOUSNESS 39 0.0003
850 ANKYLOSING SPONDYLITIS 4 0.0003
851 RENAL INJURY 9 0.0003
852 DEVICE MALFUNCTION 21 0.0003
853 FEAR 8 0.0003
854 CORONARY ARTERY DISEASE 9 0.0003
855 FREQUENT BOWEL MOVEMENTS 8 0.0003
856 BODY TEMPERATURE INCREASED 6 0.0003
857 PALLOR 8 0.0003
858 FEELING HOT 18 0.0003
859 INJECTION SITE RASH 9 0.0003
860 HAEMATURIA 10 0.0003
861 INFLUENZA LIKE ILLNESS 24 0.0003
862 INFLAMMATION 15 0.0003
863 THERAPY NON-RESPONDER 13 0.0003
864 ARTHROPATHY 16 0.0003
865 CARPAL TUNNEL SYNDROME 4 0.0003
866 ENCEPHALOPATHY 7 0.0003
867 BLOOD ALKALINE PHOSPHATASE INCREASED 7 0.0003
868 EATING DISORDER 6 0.0003
869 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 20 0.0003
870 GALLBLADDER DISORDER 5 0.0003
871 RED BLOOD CELL COUNT DECREASED 8 0.0003
872 NIGHT SWEATS 9 0.0003
873 DISORIENTATION 11 0.0003
874 PRURITUS GENERALISED 6 0.0003
875 GLYCOSYLATED HAEMOGLOBIN INCREASED 7 0.0003
876 DEVICE LEAKAGE 12 0.0003
877 CARDIOVASCULAR DISORDER 7 0.0003
878 FLUSHING 28 0.0003
879 HYPERGLYCAEMIA 10 0.0003
880 SKIN EXFOLIATION 23 0.0003
881 LIVER DISORDER 12 0.0003
882 NEUTROPHIL COUNT DECREASED 11 0.0003
883 STEVENS-JOHNSON SYNDROME 6 0.0003
884 TOOTH DISORDER 6 0.0003
885 RASH MACULO-PAPULAR 6 0.0003
886 INTERSTITIAL LUNG DISEASE 13 0.0003
887 HEPATIC STEATOSIS 5 0.0003
888 DEVICE ISSUE 24 0.0003
889 ANGER 9 0.0003
890 CHROMATURIA 6 0.0003
891 HYPERHIDROSIS 34 0.0003
892 HAEMOGLOBIN DECREASED 27 0.0003
893 INCREASED APPETITE 5 0.0003
894 MUSCLE TWITCHING 6 0.0003
895 PAIN OF SKIN 7 0.0003
896 DELIRIUM 9 0.0003
897 BURNING SENSATION 18 0.0003
898 INFUSION RELATED REACTION 17 0.0003
899 SKIN FISSURES 5 0.0003
900 DRUG DOSE OMISSION BY DEVICE 20 0.0003
901 SKIN LESION 7 0.0003
902 PARAESTHESIA 40 0.0003
903 UNEVALUABLE EVENT 19 0.0003
904 ABSCESS 4 0.0003
905 PANCYTOPENIA 14 0.0003
906 MOVEMENT DISORDER 8 0.0002
907 CRYING 9 0.0002
908 LACTIC ACIDOSIS 8 0.0002
909 FIBROMYALGIA 6 0.0002
910 DEVICE BREAKAGE 10 0.0002
911 BONE MARROW FAILURE 5 0.0002
912 INJECTION SITE URTICARIA 6 0.0002
913 ALOPECIA 48 0.0002
914 INJECTION SITE PAIN 74 0.0002
915 NEEDLE ISSUE 7 0.0002
916 CARDIO-RESPIRATORY ARREST 10 0.0002
917 TYPE 2 DIABETES MELLITUS 8 0.0002
918 HALLUCINATION, VISUAL 5 0.0002
919 INJECTION SITE SWELLING 18 0.0002
920 IMPAIRED WORK ABILITY 5 0.0002
921 EXPOSURE VIA SKIN CONTACT 6 0.0002
922 CONTRAINDICATED PRODUCT ADMINISTERED 7 0.0002
923 NIGHTMARE 8 0.0002
924 MENTAL DISORDER 10 0.0002
925 DEPRESSED LEVEL OF CONSCIOUSNESS 9 0.0002
926 ANGIOEDEMA 10 0.0002
927 ASPARTATE AMINOTRANSFERASE INCREASED 12 0.0002
928 INJECTION SITE ERYTHEMA 28 0.0002
929 COLITIS ULCERATIVE 10 0.0002
930 NEUROPATHY PERIPHERAL 21 0.0002
931 DRUG INTERACTION 35 0.0002
932 RHEUMATOID ARTHRITIS 25 0.0002
933 INJECTION SITE MASS 8 0.0002
934 MENTAL STATUS CHANGES 6 0.0002
935 BLOOD GLUCOSE DECREASED 10 0.0002
936 ADVERSE EVENT 19 0.0002
937 HEPATIC ENZYME INCREASED 14 0.0002
938 PLASMA CELL MYELOMA 8 0.0002
939 LABORATORY TEST ABNORMAL 6 0.0002
940 PSYCHOTIC DISORDER 6 0.0002
941 BLOOD GLUCOSE INCREASED 38 0.0002
942 INJECTION SITE BRUISING 16 0.0002
943 SUICIDAL IDEATION 18 0.0002
944 FEBRILE NEUTROPENIA 13 0.0002
945 CEREBRAL HAEMORRHAGE 7 0.0002
946 DRUG ADMINISTRATION ERROR 6 0.0002
947 HEPATITIS 5 0.0002
948 ACCIDENTAL EXPOSURE TO PRODUCT 20 0.0002
949 UNRESPONSIVE TO STIMULI 5 0.0002
950 DRUG-INDUCED LIVER INJURY 6 0.0002
951 JOINT STIFFNESS 5 0.0002
952 INTENTIONAL OVERDOSE 12 0.0002
953 JAUNDICE 5 0.0002
954 HYPOGLYCAEMIA 9 0.0002
955 DISTURBANCE IN ATTENTION 10 0.0002
956 THROMBOCYTOPENIA 20 0.0002
957 WHITE BLOOD CELL COUNT DECREASED 19 0.0002
958 PROSTATE CANCER 14 0.0002
959 DYSKINESIA 7 0.0002
960 COGNITIVE DISORDER 8 0.0002
961 DERMATITIS ATOPIC 9 0.0002
962 PLATELET COUNT DECREASED 18 0.0002
963 IRRITABILITY 10 0.0002
964 DISEASE PROGRESSION 19 0.0002
965 NERVOUS SYSTEM DISORDER 5 0.0002
966 PSORIASIS 20 0.0002
967 BREAST CANCER 14 0.0002
968 BREAST CANCER FEMALE 4 0.0001
969 ALANINE AMINOTRANSFERASE INCREASED 9 0.0001
970 LEUKOPENIA 7 0.0001
971 INCORRECT ROUTE OF DRUG ADMINISTRATION 5 0.0001
972 AGGRESSION 7 0.0001
973 DEVICE DISLOCATION 6 0.0001
974 NO ADVERSE EVENT 25 0.0001
975 PANCREATITIS 7 0.0001
976 SKIN IRRITATION 6 0.0001
977 SEIZURE 15 0.0001
978 DISEASE RECURRENCE 6 0.0001
979 COMA 6 0.0001
980 PSORIATIC ARTHROPATHY 5 0.0001
981 PRODUCT SUBSTITUTION ISSUE 7 0.0001
982 C-REACTIVE PROTEIN INCREASED 4 0.0001
983 MALIGNANT NEOPLASM PROGRESSION 11 0.0001
984 MULTIPLE SCLEROSIS 5 0.0001
985 NEUTROPENIA 14 0.0001
986 INJECTION SITE HAEMORRHAGE 8 0.0001
987 INJURY 7 0.0001
988 ACNE 6 0.0001
989 TOXICITY TO VARIOUS AGENTS 13 0.0001
990 DEVICE DIFFICULT TO USE 5 0.0001
991 INJECTION SITE REACTION 5 0.0001
992 TREATMENT FAILURE 6 0.0001